Traws Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $57 | $0 | $0 |
Gross Profit | 57 | |||
EBITDA | -3,131 | -6,902 | -7,324 | -3,962 |
EBIT | -3,175 | -6,946 | -7,368 | -4,055 |
Net Income | -3,054 | -3,054 | -7,443 | -3,035 |
Net Change In Cash | 0 | 57 | 0 | 0 |
Free Cash Flow | -7,504 | -2,576 | -2,758 | -4,011 |
Cash | 5,016 | 3,133 | 3,820 | 6,420 |
Basic Shares | 15,264 | 10,640 | 9,067 | 8,819 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,790 | $226 | $226 | $226 |
Gross Profit | 2,790 | 214 | 226 | 226 |
EBITDA | -17,814 | -166,511 | -20,282 | -19,613 |
EBIT | -17,875 | -166,523 | -20,298 | -19,627 |
Net Income | 9,170 | -54,674 | -18,948 | -18,964 |
Net Change In Cash | 2,790 | 226 | 226 | 226 |
Free Cash Flow | -20,770 | -29,792 | -17,946 | -16,294 |
Cash | 3,820 | 21,338 | 20,821 | 38,757 |
Basic Shares | 8,376 | 1,552 | 839 | 836 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.16 |
2026-03-31 | -$0.52 |
2025-12-31 | -$0.55 |
2025-09-30 | -$0.34 |